T1	Treatment 50 94	estradiol and trimegestone or dydrogesterone
T2	Treatment 160 211	estradiol/trimegestone or estradiol/dydrogesterone.
T3	Treatment 327 447	6 cycles of either estradiol (2mg)+trimegestone (0.5mg) (T-group) or estradiol (2mg)+dydrogesterone (10mg) (DYDR group).
T4	Treatment 448 551	Cardiovascular risk markers were measured before, after cycle 1, 3 and 6 and at 4 weeks post-treatment.
